Difficulty: Medium
Average Score: 84%
Practice
Azathiprone
Correct answer
D
Rationale
Azathioprine is an immunosuppressive chemotherapy drug commonly used in conditions like autoimmune diseases and organ transplantation. The correct answer, option D, states that azathioprine is markedly hematotoxic and has caused neoplasms. This is accurate because azathioprine can suppress bone marrow function, leading to hematologic toxicity such as leukopenia, thrombocytopenia, and anemia. Additionally, long-term use of azathioprine has been associated with an increased risk of developing certain types of cancers.
Option A, which states that azathioprine binds avidly to a cytoplasmic immunophillin, is incorrect. While azathioprine does bind to proteins within cells, its mechanism of action primarily involves interfering with DNA synthesis rather than binding to immunophillins.
Option B, which suggests that azathioprine blocks the formation of tetrahydrofolic acid, is also incorrect. This statement is more aligned with the mechanism of action of drugs like methotrexate, which inhibits dihydrofolate reductase, leading to the depletion of tetrahydrofolic acid.
Option C, claiming that azathioprine is a precursor of cytarabine, is inaccurate. Cytarabine is a different chemotherapy drug with a distinct mechanism of action and clinical use compared to azathioprine.
In an educational context, understanding the mechanisms of action and side effects of chemotherapy drugs like azathioprine is crucial for nurses, pharmacists, and other healthcare professionals involved in the administration and monitoring of these medications. This knowledge helps ensure safe and effective patient care, including appropriate monitoring for potential adverse effects and interactions.
Option A, which states that azathioprine binds avidly to a cytoplasmic immunophillin, is incorrect. While azathioprine does bind to proteins within cells, its mechanism of action primarily involves interfering with DNA synthesis rather than binding to immunophillins.
Option B, which suggests that azathioprine blocks the formation of tetrahydrofolic acid, is also incorrect. This statement is more aligned with the mechanism of action of drugs like methotrexate, which inhibits dihydrofolate reductase, leading to the depletion of tetrahydrofolic acid.
Option C, claiming that azathioprine is a precursor of cytarabine, is inaccurate. Cytarabine is a different chemotherapy drug with a distinct mechanism of action and clinical use compared to azathioprine.
In an educational context, understanding the mechanisms of action and side effects of chemotherapy drugs like azathioprine is crucial for nurses, pharmacists, and other healthcare professionals involved in the administration and monitoring of these medications. This knowledge helps ensure safe and effective patient care, including appropriate monitoring for potential adverse effects and interactions.